The reduction of IL-1β, TNF-α, IL-6, and RANKL levels after dietary supplementation with n-3 PUFA as an adjunctive therapy for periodontitis was the most prevalent among the reviewed studies. This evidence concerns the gene IL1B and periodontitis.